MORGAN STANLEY

Holdings History for TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Symbol: TXMD on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$210,624	129,217	-1,355	-1%	$1.63	Q4 2025
30 Sep 2025	0%	0%	$140,365	130,572	-638	-0.49%	$1.08	Q3 2025
30 Jun 2025	0%	0%	$152,203	131,210	0		$1.16	Q2 2025
31 Mar 2025	0%	0%	$121,368	131,210	-1,179		$0.92	Q1 2025
31 Dec 2024	0%	0%	$113,855	132,389	+670		$0.86	Q4 2024
30 Sep 2024	0%	0%	$218,654	131,719	+118		$1.66	Q3 2024
30 Jun 2024	0%	0%	$211,877	131,601	-91		$1.61	Q2 2024
31 Mar 2024	0%	0%	$301,575	131,692	-75	-0.06%	$2.29	Q1 2024
31 Dec 2023	0%	0%	$296,476	131,767	-1,377	-1%	$2.25	Q4 2023
30 Sep 2023	0%	0%	$402,095	133,144	-584	-0.44%	$3.02	Q3 2023
30 Jun 2023	0%	0%	$550,960	133,728	0		$4.12	Q2 2023
31 Mar 2023	0%	0%	$501,480	133,728	+247	+0.19%	$3.75	Q1 2023
31 Dec 2022	0%	-0%	$746,159	133,481	-3,098	-2.3%	$5.59	Q4 2022
30 Sep 2022	0%	-0%	$907,000	136,579	-4,036	-2.9%	$6.64	Q3 2022
30 Jun 2022	0%	+0%	$1,399,000	140,615	+140,615	NEW	$9.95	Q2 2022
30 Jun 2022		0%	$4,000	317	0		$12.62 ^*	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.